权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Cellular Determinants and Function Consequences of PP2A-B56 Degradation by HIV-1 Vif

HIV-1 Vif 降解 PP2A-B56 的细胞决定因素和功能后果

基本信息

批准号：
10619722
负责人：
Jeffrey R Johnson
金额：
$ 55.14万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-05-05 至 2027-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10619722
关键词：
APOCEC3G gene Acquired Immunodeficiency Syndrome Address Affinity Chromatography Binding Biological Assay CD4 Positive T Lymphocytes CRISPR screen CRISPR/Cas technology Cell Line Cells Chronic Data Development Drug Targeting Environment Event Family Flow Cytometry Fluorescence Gene Silencing Genes Genetic Screening HIV-1 Holoenzymes Human Individual Infection Inflammation Inflammatory Label Malignant Neoplasms Mass Spectrum Analysis Measures Mediating Metabolic Diseases Molecular Molecular Virology Pathway interactions Persons Phosphorylation Phosphorylation Site Play Process Protein Family Protein Subunits Protein phosphatase Proteins Proteomics Resources Retroviridae Role Signal Transduction Site Technology Testing Translations Ubiquitination Viral Viral Physiology Virion Work antiretroviral therapy base editing cDNA Expression candidate identification cardiovascular disorder risk community transmission drug development engineered T cells fitness genome-wide multidisciplinary novel phosphoproteomics prevent protein complex protein degradation reactivation from latency targeted treatment therapy development vif Gene Products virology virus host interaction

项目摘要

PROJECT SUMMARY The HIV-1 Vif protein is expressed late during infection and has a well-described function to ubiquitinate and degrade proteins in the APOBEC3 family, thus neutralizing their antiviral activities. More recently, an additional function of HIV-1 Vif was described by us and others to ubiquitinate and degrade protein phosphatase 2A holoenzymes containing B56 family regulatory subunits (PP2A-B56). The conservation of Vif-mediated PP2A- B56 degradation throughout globally circulating HIV-1 subtypes suggests that it is functionally important. However, there remains a gap in understanding the mechanisms by which PP2A-B56 degradation confers a fitness advantage to HIV-1. Furthermore, in contrast to APOBEC3 degradation, the host cellular determinants required for Vif-mediated ubiquitination and degradation of PP2A-B56 are undefined. In this project, we aim to address these gaps in understanding by defining the cellular determinants and functional effects of PP2A-B56 degradation by HIV-1 Vif. In Aim 1, we will apply unbiased protein interaction technologies to determine proteins interacting with PP2A-B56 while it is degraded by Vif. In Aim 2, we will carry out a genome- wide CRISPR/Cas9 genetic screen to identify genes regulating APOBEC3 and PP2A-B56 degradation. In Aim 3, will test the impact of individual phosphorylation sites regulated by PP2A-B56 in HIV-1 replication in primary CD4+ T cells. Successful completion of this project will advance understanding of the Vif-PP2A-B56 signaling axis, potentially leading towards the development of novel classes of antiretroviral therapies that target late processes of HIV-1 infection.

项目总结